🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused measures to deal with cost of living challenges" in next month's Budget.

In comments to media outlets, she stated that curbing inflation is a shared responsibility of both the administration and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven developed nations this calendar year and the following year.

Possible Energy Cost Measures

Sources suggest the administration could intervene to reduce utility costs, for example by reducing the present 5% rate of VAT applied on energy supplies.

A further possibility is to cut some of the regulatory levies presently included in bills.

Fiscal Constraints and Analyst Expectations

The government will obtain the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much room there is for such actions.

The view from the majority of experts is that Reeves will have to announce tax rises or budget cuts in order to adhere to her self-imposed borrowing rules.

Previously on the same day, calculations showed there was a twenty-two billion pound gap for the chancellor to fill, which is at the more modest range of projections.

"It is a shared job between the central bank and the administration to further reduce some of the drivers of inflation," the Chancellor informed reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the focus has been on likely tax rises, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and trade concerns for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."

Global Trade Disputes

Commenting on concerns about the UK's economic relations with the Asian nation she said: "Our national security invariably take priority."

Last week's declaration by China to strengthen trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an additional 100% tariff on goods from China, raising the prospect of an full-scale commercial conflict between the two largest economies.

The American finance chief described China's action "commercial pressure" and "a international production power grab."

Asked about accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the international commerce and generates further obstacles."

"In my view there are sectors where we must challenge China, but there are also valuable chances to sell into Chinese markets, including banking sector and other areas of the economy. We've got to get that equilibrium correct."

The chancellor also confirmed she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are reduced dependence."

NHS Medicine Pricing and Funding

The Chancellor also admitted that the price the NHS pays for medicines could go up as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either delaying or abandoning operations in the UK, with some blaming the insufficient payments they are receiving.

Recently, the government science advisor said the price the health service spends on drugs would need to rise to prevent businesses and drug research funding leaving the United Kingdom.

Reeves informed media: "It has been observed as a result of the payment system, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other EU nations."

"Our aim is to ensure that individuals receiving care from the NHS are able to receive the top essential medicines in the world. And so we are reviewing these issues, and... seeking to secure additional capital into Britain."